✦ LIBER ✦

Small-cell carcinoma of the lung: A five-year experience with combined modality therapy

✍ Scribed by Philip C. Hoffman; Harvey M. Golomb; Jacob D. Bitran; Tom R. Demeester; Lionel Cohen; Melvin L. Griem; Judith A. Cooksey; Uri Mintz; Leo I. Gordon; Richard K. Desser; Ann E. Kinnealey; Corinne A. Sovik

Publisher: John Wiley and Sons
Year: 1980
Tongue: English
Weight: 599 KB
Volume: 46
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19801215)46:12<2550::aid-cncr2820461203>3.0.co;2-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A 10-year experience with combined modal

A 10-year experience with combined modality therapy for stage III small cell lung carcinoma

✍ Renee H. Jacobs; Alice Greenburg; Jacob D. Bitran; Philip C. Hoffman; Kathy S. A 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 693 KB

During the past 10 years, 240 patients with Stage I11 small cell lung carcinoma (SCLC) were treated with one of five chemotherapy programs plus thoracic irradiation. In addition, prophylactic cranial irradiation was administered concurrently with thoracic irradiation to 194 patients receiving CAML-H

Combined modality therapy for stage IIIM

Combined modality therapy for stage IIIMO non-small cell lung cancer. A five-year experience

✍ Patricia J. Madej; Jacob D. Bitran; Harvey M. Golomb; Philip G. Hoffman Jr; Thom 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 720 KB

Between 1975 and 1980, 101 patients with inoperable Stage IIIMO non-small cell lung carcinoma were entered into combined radiotherapy and chemotherapy trials at Michael Reese Hospital and University of Chicago Hospital. Sixty-four percent of the patients responded. Median survival for all patients w

Results of combined-modality therapy for

Results of combined-modality therapy for limited-stage small cell lung carcinoma in the elderly

✍ Steven E. Schild; Philip J. Stella; Burke J. Brooks; Sumithra Mandrekar; James A 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 2 views

## Abstract ## BACKGROUND A Phase III trial was conducted by the North Central Cancer Treatment Group to determine whether chemotherapy (etoposide and cisplatin) plus either twice‐daily radiotherapy (BIDRT) or once‐daily radiotherapy (QDRT) resulted in a better outcome for patients with limited‐st

Small cell carcinoma of the lung. A prog

Small cell carcinoma of the lung. A progress report of 15 years' experience

✍ Noah C. Choi; Robert W. Carey; S. Donald Kaufman; Hermes C. Grillo; Jerry Younge 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 884 KB

To assess the results of therapeutic advances in the treatment of small cell carcinoma of the lung (SCCL) achieved during the past 15-year period at a single large institution, 508 patients treated between 1968 and 1982 were divided into two groups: 157 patients (66 in the category of limited-stage

Small cell carcinoma of the lung experie

Small cell carcinoma of the lung experience with a six-drug regimen

✍ John S. Sierocki; Basil S. Hilaris; Seymour Hopfan; Robert B. Golbey; Dr. Robert 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 468 KB 👁 2 views

Combination chemotherapy and radiation t

Combination chemotherapy and radiation therapy in small cell carcinoma of the lung

✍ Robert T. Eagan; L. Herbert Maurer; R. Jackson Forcier; Marchant Tulloh 📂 Article 📅 1973 🏛 John Wiley and Sons 🌐 English ⚖ 786 KB

Twenty-eight patients with small cell carcinoma of the lung were studied for their response to combination chemotherapy and radiation therapy, frequency of bone marrow metastases, and clinically evident hormonal syndromes. Seventeen of 19 evaluable patients who received cyclic monthly courses of hig